Baxter launches premixed eptifibatide in flexible container

|About: Baxter International Inc. (BAX)|By:, SA News Editor

Baxter International (NYSE:BAX) announces the U.S. approval and market launch of ready-to-use eptifibatide in a flexible container. The company says the new formulation will cut the time and effort required to deliver the anti-clotting med to patients by hospital pharmacists.

Eptifibatide is indicated for the treatment of patients with acute coronary syndrome and those undergoing percutaneous coronary intervention.

Subscribe for full text news in your inbox